Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $313.68 | 16 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $177.27 | 10 | $0 (2024) |
| Lilly USA, LLC | $80.76 | 4 | $0 (2024) |
| ABBVIE INC. | $34.21 | 1 | $0 (2024) |
| Kyowa Kirin, Inc. | $21.44 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $294.86 | 15 | Novo Nordisk Inc ($177.27) |
| 2023 | $18.82 | 1 | Lilly USA, LLC ($18.82) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Obesity | ||||||
| 10/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $25.18 | General |
| 09/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Obesity | ||||||
| 06/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: Diabetes | ||||||
| 05/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Obesity | ||||||
| 04/25/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $17.64 | General |
| 02/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.21 | General |
| Category: NEUROSCIENCE | ||||||
| 02/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Obesity | ||||||
| 01/16/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 12/14/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 358 | 380 | $68,584 | $21,344 |
| 2022 | 8 | 381 | 386 | $87,372 | $23,401 |
| 2021 | 5 | 238 | 242 | $64,989 | $14,166 |
| 2020 | 3 | 184 | 186 | $50,863 | $8,015 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 161 | 178 | $33,728 | $10,568 | 31.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 94 | 94 | $23,355 | $6,486 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 29 | $6,863 | $2,754 | 40.1% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 19 | 19 | $2,278 | $955.32 | 41.9% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2023 | 14 | 14 | $1,946 | $481.46 | 24.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 42 | 46 | $414.00 | $99.60 | 24.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 183 | 187 | $44,257 | $11,783 | 26.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 55 | 55 | $13,640 | $4,544 | 33.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 33 | $13,849 | $2,602 | 18.8% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2022 | 21 | 21 | $6,951 | $1,971 | 28.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $5,364 | $1,162 | 21.7% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 14 | 14 | $1,400 | $703.92 | 50.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 15 | 15 | $1,050 | $526.80 | 50.2% |
| 81003 | Automated urinalysis test | Office | 2022 | 48 | 49 | $861.00 | $108.66 | 12.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 151 | 154 | $45,430 | $9,629 | 21.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 38 | 39 | $16,965 | $3,741 | 22.0% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 16 | 16 | $1,120 | $565.28 | 50.5% |
| 87880 | Strep test by immunoassay for streptococcus | Office | 2021 | 11 | 11 | $880.00 | $181.83 | 20.7% |
| 81003 | Automated urinalysis test | Office | 2021 | 22 | 22 | $594.00 | $49.50 | 8.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 131 | 133 | $37,373 | $6,007 | 16.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 31 | 31 | $12,896 | $1,960 | 15.2% |
| 81003 | Automated urinalysis test | Office | 2020 | 22 | 22 | $594.00 | $48.05 | 8.1% |
About Dr. Theodore Derse, MD
Dr. Theodore Derse, MD is a Family Medicine healthcare provider based in Zebulon, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336254515.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Theodore Derse, MD has received a total of $313.68 in payments from pharmaceutical and medical device companies, with $294.86 received in 2024. These payments were reported across 16 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($313.68).
As a Medicare-enrolled provider, Derse has provided services to 1,161 Medicare beneficiaries, totaling 1,194 services with total Medicare billing of $66,927. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine, Family Medicine
- Location Zebulon, NC
- Active Since 08/20/2006
- Last Updated 03/25/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1336254515
Products in Payments
- Wegovy (Drug) $68.51
- Ozempic (Drug) $60.17
- MOUNJARO (Drug) $37.74
- VRAYLAR (Drug) $34.21
- JARDIANCE (Drug) $25.38
- Rybelsus (Drug) $23.41
- Crysvita (Drug) $21.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Zebulon
Dr. Donna Haney, M.d, M.D
Family Medicine — Payments: $676.39
Octavia Graham, Md, MD
Family Medicine — Payments: $212.91
Dr. Christopher Wozniak, D.o, D.O
Family Medicine — Payments: $122.58
Tom John Mayuga, Do, DO
Family Medicine — Payments: $61.81
Dr. Marcella Mccord, Md, MD
Family Medicine
Henry Mascarenhas, Dnp, DNP
Family Medicine